Abdominal aortic aneurysm (AAA) is a ballooning of the aorta, the largest blood vessel in the human body, which extends into the abdomen. If the wall of this blood vessel becomes weakened, it can stretch, "balloon" out and rupture. A rupture, if left untreated, can lead to life-threatening internal bleeding. The exact cause of this condition is unknown. However, it often occurs in older adults, especially males, those with a high cholesterol level, and in smokers. There also tends to be a genetic link to this disorder.
A breakthrough medical technology can save the lives of children with heart defects. Scientists have developed the first-ever heart valve that grows with the child, reducing the need for risky heart surgeries in the future.
When 64-year-old Robert Johnson of Highland, Indiana thought he had kidney stones, he visited his primary care physician who couldn't see anything of concern. He pushed, saying "I'm not making up this pain. It's waking me up every night."
A common cardiac blood test done before surgery can predict who will experience adverse outcomes after most types of surgery, says an international study led by Hamilton researchers.
An abdominal aortic aneurysm is a focal dilation of the abdominal aorta, that if not treated, tends to grow and may rupture. The most common treatment is EndoVascular Aneurysm Repair (EVAR), which requires patients to undergo lifelong postoperative surveillance based on computed tomography angiography (CTA) due to the possible appearance of complications. These complications may again lead to aneurysm dilation and rupture.
It is the 'silent killer' that claimed the life of Albert Einstein and affects 1% of men over the age of 65, but researchers at the University of Dundee believe they may be able to reduce the number of fatalities caused by abdominal aortic aneurysms.
When James Inman, 59, first experienced chest pain one night, he tried to brush it off and go back to sleep. But the pain became unbearable and Inman felt like something was wrong, so he called 911.
A new study of New York City firefighters has found that exposure to 9/11 World Trade Center dust is associated with a significantly increased long-term risk of cardiovascular disease.
The notion that more medical errors occur in July compared to other months due to an influx of new medical school graduates starting their in-hospital training does not apply to heart surgery, according to research in The Annals of Thoracic Surgery, published by Elsevier.
The system connects the arteries to the veins. There are 100,000 miles of blood vessels in the adult human body.
The pivotal trial to determine the safety and effectiveness of a modular device designed to be the first completely off-the-shelf endovascular solution for aortic aneurysms involving the visceral branch vessels is successfully underway with its first surgery at UNC Hospitals in Chapel Hill, NC.
Researchers have discovered that a family of lipids (fats) contribute to the development of a serious aortic disease, by driving clotting in the blood vessel wall.
Paracetamol or other painkillers taken during pregnancy are unlikely to cause asthma in the child, according to a large study by researchers at Karolinska Institutet and Queen Mary University of London.
We know that antibiotics treat bacterial infections. We also know why they work. Tetracycline antibiotics, for example, stop bacteria from making protein. Like a boot on a wheel, the drugs bind to the bacterial cell's ribosome--where protein is made--and prevent it from working. Without protein, the bacteria weaken and die.
Ultrasound conducted before a patient develops symptoms could improve early detection of diseases in blood vessels, research led by the University of Leicester has shown.
Researchers centered at the University of Tsukuba and Kansai Medical University in Japan reveal matricellular protein Thrombospondin-1 (Thbs1) contributes to the development of aortic aneurysm in mice and humans.
A new research hub is set to transform Australia’s medical technology sector by developing cost-competitive technologies for the rapid production of medical devices.
During the 12 months after undergoing noncardiac surgery, patients with or at risk for heart disease who were treated with the beta blocker metoprolol for 30 days were less likely than patients who received a placebo to have a heart attack, but more likely to die or have a stroke, according to research presented at the American College of Cardiology's 67th Annual Scientific Session.
Researchers in Hamilton have discovered that a blood-thinning drug, dabigatran, significantly reduces the risk of death, heart attack, stroke, and other heart or blood-vessel complications in patients who have a heart injury following major, non-cardiac surgery.
New research from a Swedish and Danish team of researchers led from Karolinska Institutet lend additional support to a link between treatment with fluoroquinolone antibiotics and an increased risk of acute aortic disease. The study is published in the esteemed journal The BMJ.
The Affordable Care Act's Medicaid expansion was linked to better access to surgery and higher quality surgical care, according to a new study from Harvard T.H. Chan School of Public Health.